{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:30:49Z","timestamp":1759159849867,"version":"3.37.3"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The recent emergence of a\u00a0new coronavirus (severe acute respiratory syndrome coronavirus\u20112, SARS-CoV-2) that is transmitted efficiently among humans and can result in serious disease and\/or death has become a\u00a0global threat to public health and economy. In this article, we describe some of the most important characteristics of this new virus (including gaps in our understanding) and provide a\u00a0perspective of ongoing activities for developing virus-specific countermeasures, such as vaccines and antiviral drugs.<\/jats:p>","DOI":"10.1007\/s00508-020-01763-1","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T14:02:45Z","timestamp":1604066565000},"page":"635-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Profile of SARS-CoV-2"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-4331","authenticated-orcid":false,"given":"Franz X.","family":"Heinz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Stiasny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"4","key":"1763_CR1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","volume":"26","author":"KG Andersen","year":"2020","unstructured":"Andersen\u00a0KG, Rambaut\u00a0A, Lipkin\u00a0WI, Holmes\u00a0EC, Garry\u00a0RF. The proximal origin of SARS-CoV\u20112. Nat Med. 2020;26(4):450\u20132.","journal-title":"Nat Med"},{"issue":"1","key":"1763_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","volume":"25","author":"D Forni","year":"2017","unstructured":"Forni\u00a0D, Cagliani\u00a0R, Clerici\u00a0M, Sironi\u00a0M. Molecular evolution of human Coronavirus genomes. Trends Microbiol. 2017;25(1):35\u201348.","journal-title":"Trends Microbiol"},{"issue":"3","key":"1763_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui\u00a0J, Li\u00a0F, Shi\u00a0Z\u2011L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181\u201392.","journal-title":"Nat Rev Microbiol"},{"key":"1763_CR4","doi-asserted-by":"publisher","unstructured":"Khamassi Khbou M, Daaloul Jedidi M, Bouaicha Zaafouri F, Benzarti Mh. Coronaviruses in farm animals: Epidemiology and public health implications. Veterinary Medicine and Science. 2020. https:\/\/doi.org\/10.1002\/vms3.359","DOI":"10.1002\/vms3.359"},{"issue":"12","key":"1763_CR5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","volume":"11","author":"RL Graham","year":"2013","unstructured":"Graham\u00a0RL, Donaldson\u00a0EF, Baric\u00a0RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 2013;11(12):836\u201348.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"1763_CR6","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","volume":"20","author":"A Wilder-Smith","year":"2020","unstructured":"Wilder-Smith\u00a0A, Chiew\u00a0CJ, Lee\u00a0VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020;20(5):e102\u2013e7.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1763_CR7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit\u00a0E, van Doremalen\u00a0N, Falzarano\u00a0D, Munster\u00a0VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523\u201334.","journal-title":"Nat Rev Microbiol"},{"key":"1763_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coviro.2016.01.004","volume":"16","author":"CBEM Reusken","year":"2016","unstructured":"Reusken\u00a0CBEM, Raj\u00a0VS, Koopmans\u00a0MP, Haagmans\u00a0BL. Cross host transmission in the emergence of MERS coronavirus. Curr Opin Virol. 2016;16:55\u201362.","journal-title":"Curr Opin Virol"},{"issue":"10229","key":"1763_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(19)33221-0","volume":"395","author":"ZA Memish","year":"2020","unstructured":"Memish\u00a0ZA, Perlman\u00a0S, Van Kerkhove\u00a0MD, Zumla\u00a0A. Middle East respiratory syndrome. Lancet. 2020;395(10229):1063\u201377.","journal-title":"Lancet"},{"issue":"7477","key":"1763_CR10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","volume":"503","author":"X-Y Ge","year":"2013","unstructured":"Ge\u00a0X\u2011Y, Li\u00a0J\u2011L, Yang\u00a0X\u2011L, Chmura\u00a0AA, Zhu\u00a0G, Epstein\u00a0JH, et al. Isolation and characterization of a\u00a0bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503(7477):535\u20138.","journal-title":"Nature"},{"issue":"12","key":"1763_CR11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","volume":"21","author":"VD Menachery","year":"2015","unstructured":"Menachery\u00a0VD, Yount\u00a0BL Jr., Debbink\u00a0K, Agnihothram\u00a0S, Gralinski\u00a0LE, Plante\u00a0JA, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med. 2015;21(12):1508\u201313.","journal-title":"Nat Med"},{"key":"1763_CR12","unstructured":"World Health Organization (WHO). Weekly Epidemiological Update 2020. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports. Accessed on: October 28, 2020."},{"issue":"3","key":"1763_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"A Wu","year":"2020","unstructured":"Wu\u00a0A, Peng\u00a0Y, Huang\u00a0B, Ding\u00a0X, Wang\u00a0X, Niu\u00a0P, et al. Genome composition and divergence of the novel Coronavirus (2019-ncoV) originating in China. Cell Host Microbe. 2020;27(3):325\u20138.","journal-title":"Cell Host Microbe"},{"key":"1763_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2014.06.013","volume":"109","author":"DX Liu","year":"2014","unstructured":"Liu\u00a0DX, Fung\u00a0TS, Chong\u00a0KK\u2011L, Shukla\u00a0A, Hilgenfeld\u00a0R. Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Res. 2014;109:97\u2013109.","journal-title":"Antiviral Res"},{"issue":"13","key":"1763_CR15","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0508200103","volume":"103","author":"E Minskaia","year":"2006","unstructured":"Minskaia\u00a0E, Hertzig\u00a0T, Gorbalenya\u00a0AE, Campanacci\u00a0V, Cambillau\u00a0C, Canard\u00a0B, et\u00a0al. Discovery of an RNA virus 3\u2032\u21925\u2032 exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci USA. 2006;103(13):5108.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"1763_CR16","doi-asserted-by":"crossref","first-page":"R849","DOI":"10.1016\/j.cub.2020.06.031","volume":"30","author":"T Day","year":"2020","unstructured":"Day\u00a0T, Gandon\u00a0S, Lion\u00a0S, Otto\u00a0SP. On the evolutionary epidemiology of SARS-CoV\u20112. Curr Biol. 2020;30(15):R849\u2013R57.","journal-title":"Curr Biol"},{"key":"1763_CR17","doi-asserted-by":"publisher","unstructured":"Yao H, Song Y, Chen Y, Wu N, Xu J, Sun C, et al. Molecular Architecture of the SARS-CoV-2 Virus. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.09.018.","DOI":"10.1016\/j.cell.2020.09.018"},{"key":"1763_CR18","doi-asserted-by":"crossref","first-page":"e57877","DOI":"10.7554\/eLife.57877","volume":"9","author":"PJ Klasse","year":"2020","unstructured":"Klasse\u00a0PJ, Moore\u00a0JP. Antibodies to SARS-CoV\u20112 and their potential for therapeutic passive immunization. Elife. 2020;9:e57877.","journal-title":"Elife"},{"key":"1763_CR19","doi-asserted-by":"crossref","first-page":"104792","DOI":"10.1016\/j.antiviral.2020.104792","volume":"178","author":"T Tang","year":"2020","unstructured":"Tang\u00a0T, Bidon\u00a0M, Jaimes\u00a0JA, Whittaker\u00a0GR, Daniel\u00a0S. Coronavirus membrane fusion mechanism offers a\u00a0potential target for antiviral development. Antiviral Res. 2020;178:104792.","journal-title":"Antiviral Res"},{"issue":"6483","key":"1763_CR20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp\u00a0D, Wang\u00a0N, Corbett\u00a0KS, Goldsmith\u00a0JA, Hsieh\u00a0C\u2011L, Abiona\u00a0O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260.","journal-title":"Science"},{"issue":"2","key":"1763_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls\u00a0AC, Park\u00a0Y\u2011J, Tortorici\u00a0MA, Wall\u00a0A, McGuire\u00a0AT, Veesler\u00a0D. Structure, Function, and Antigenicity of the SARS-CoV\u20112 Spike Glycoprotein. Cell. 2020;181(2):281\u2013292.e6.","journal-title":"Cell"},{"issue":"6485","key":"1763_CR22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan\u00a0R, Zhang\u00a0Y, Li\u00a0Y, Xia\u00a0L, Guo\u00a0Y, Zhou\u00a0Q. Structural basis for the recognition of SARS-CoV\u20112 by full-length human ACE2. Science. 2020;367(6485):1444\u20138.","journal-title":"Science"},{"issue":"1","key":"1763_CR23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF Chan","year":"2020","unstructured":"Chan\u00a0JF, Kok\u00a0KH, Zhu\u00a0Z, Chu\u00a0H, To\u00a0KK, Yuan\u00a0S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a\u00a0patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221\u201336.","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"1763_CR24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann\u00a0M, Kleine-Weber\u00a0H, Schroeder\u00a0S, Kr\u00fcger\u00a0N, Herrler\u00a0T, Erichsen\u00a0S, et al. SARS-coV\u20112 cell entry depends on ACE2 and TMPRSS2 and is blocked by a\u00a0clinically proven protease inhibitor. Cell. 2020;181(2):271\u2013280.e8.","journal-title":"Cell"},{"issue":"2","key":"1763_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/2049-632X.12053","volume":"69","author":"E B\u00f6ttcher-Friebertsh\u00e4user","year":"2013","unstructured":"B\u00f6ttcher-Friebertsh\u00e4user\u00a0E, Klenk\u00a0H\u2011D, Garten\u00a0W. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium. Pathogens Disease. 2013;69(2):87\u2013100.","journal-title":"Pathogens Disease"},{"key":"1763_CR26","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard\u00a0B, Valle\u00a0C, de Lamballerie\u00a0X, Canard\u00a0B, Seidah\u00a0NG, Decroly\u00a0E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a\u00a0furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742.","journal-title":"Antiviral Res"},{"issue":"2","key":"1763_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","volume":"181","author":"Y-Z Zhang","year":"2020","unstructured":"Zhang\u00a0Y\u2011Z, Holmes\u00a0EC. A genomic perspective on the origin and emergence of SARS-coV\u20112. Cell. 2020;181(2):223\u20137.","journal-title":"Cell"},{"issue":"7807","key":"1763_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan\u00a0J, Ge\u00a0J, Yu\u00a0J, Shan\u00a0S, Zhou\u00a0H, Fan\u00a0S, et al. Structure of the SARS-CoV\u20112 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215\u201320.","journal-title":"Nature"},{"issue":"4","key":"1763_CR29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang\u00a0Q, Zhang\u00a0Y, Wu\u00a0L, Niu\u00a0S, Song\u00a0C, Zhang\u00a0Z, et al. Structural and functional basis of SARS-coV\u20112 entry by using human ACE2. Cell. 2020;181(4):894\u2013904.e9.","journal-title":"Cell"},{"issue":"12","key":"1763_CR30","doi-asserted-by":"crossref","first-page":"108185","DOI":"10.1016\/j.celrep.2020.108185","volume":"32","author":"Y Konno","year":"2020","unstructured":"Konno\u00a0Y, Kimura\u00a0I, Uriu\u00a0K, Fukushi\u00a0M, Irie\u00a0T, Koyanagi\u00a0Y, et al. SARS-coV\u20112 ORF3b is a\u00a0potent interferon antagonist whose activity is increased by a\u00a0naturally occurring elongation variant. Cell Rep. 2020;32(12):108185.","journal-title":"Cell Rep"},{"issue":"7798","key":"1763_CR31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou\u00a0P, Yang\u00a0X\u2011L, Wang\u00a0X\u2011G, Hu\u00a0B, Zhang\u00a0L, Zhang\u00a0W, et al. A pneumonia outbreak associated with a\u00a0new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.","journal-title":"Nature"},{"key":"1763_CR32","doi-asserted-by":"publisher","unstructured":"Boni MF, Lemey P, Jiang X, Lam TT-Y, Perry BW, Castoe TA, et al. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiology. 2020;5(11):1408\u201317. https:\/\/doi.org\/10.1038\/s41564-020-0771-4.","DOI":"10.1038\/s41564-020-0771-4"},{"issue":"5","key":"1763_CR33","doi-asserted-by":"crossref","first-page":"e1008421","DOI":"10.1371\/journal.ppat.1008421","volume":"16","author":"P Liu","year":"2020","unstructured":"Liu\u00a0P, Jiang\u00a0JZ, Wan\u00a0XF, Hua\u00a0Y, Li\u00a0L, Zhou\u00a0J, et al. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog. 2020;16(5):e1008421.","journal-title":"PLoS Pathog"},{"issue":"7815","key":"1763_CR34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-020-2169-0","volume":"583","author":"TT-Y Lam","year":"2020","unstructured":"Lam\u00a0TT\u2011Y, Jia\u00a0N, Zhang\u00a0Y\u2011W, Shum\u00a0MH\u2011H, Jiang\u00a0J\u2011F, Zhu\u00a0H\u2011C, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583(7815):282\u20135.","journal-title":"Nature"},{"issue":"7815","key":"1763_CR35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41586-020-2313-x","volume":"583","author":"K Xiao","year":"2020","unstructured":"Xiao\u00a0K, Zhai\u00a0J, Feng\u00a0Y, Zhou\u00a0N, Zhang\u00a0X, Zou\u00a0J\u2011J, et al. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature. 2020;583(7815):286\u20139.","journal-title":"Nature"},{"key":"1763_CR36","doi-asserted-by":"publisher","unstructured":"Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, et al. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.09.032.","DOI":"10.1016\/j.cell.2020.09.032"},{"issue":"4","key":"1763_CR37","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2020.06.040","volume":"182","author":"ND Grubaugh","year":"2020","unstructured":"Grubaugh\u00a0ND, Hanage\u00a0WP, Rasmussen\u00a0AL. Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear. Cell. 2020;182(4):794\u20135.","journal-title":"Cell"},{"issue":"38","key":"1763_CR38","doi-asserted-by":"crossref","first-page":"23652","DOI":"10.1073\/pnas.2008281117","volume":"117","author":"B Dearlove","year":"2020","unstructured":"Dearlove\u00a0B, Lewitus\u00a0E, Bai\u00a0H, Li\u00a0Y, Reeves\u00a0DB, Joyce\u00a0MG, et al. A SARS-CoV\u20112 vaccine candidate would likely match all currently circulating variants. Proc Natl Acad Sci. 2020;117(38):23652.","journal-title":"Proc Natl Acad Sci"},{"issue":"10251","key":"1763_CR39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(20)31757-8","volume":"396","author":"BE Young","year":"2020","unstructured":"Young\u00a0BE, Fong\u00a0S\u2011W, Chan\u00a0Y\u2011H, Mak\u00a0T\u2011M, Ang\u00a0LW, Anderson\u00a0DE, et al. Effects of a\u00a0major deletion in the SARS-CoV\u20112 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet. 2020;396(10251):603\u201311.","journal-title":"Lancet"},{"key":"1763_CR40","doi-asserted-by":"crossref","first-page":"110678","DOI":"10.1016\/j.biopha.2020.110678","volume":"131","author":"M Dong","year":"2020","unstructured":"Dong\u00a0M, Zhang\u00a0J, Ma\u00a0X, Tan\u00a0J, Chen\u00a0L, Liu\u00a0S, et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother. 2020;131:110678.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1763_CR41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya\u00a0AE, Baker\u00a0SC, Baric\u00a0RS, de Groot\u00a0RJ, Drosten\u00a0C, Gulyaeva\u00a0AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV\u20112. Nat Microbiol. 2020;5(4):536\u201344.","journal-title":"Nat Microbiol"},{"key":"1763_CR42","doi-asserted-by":"publisher","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, et al. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020;33(1):108234. https:\/\/doi.org\/10.1016\/j.celrep.2020.108234.","DOI":"10.1016\/j.celrep.2020.108234"},{"issue":"1","key":"1763_CR43","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei\u00a0X, Dong\u00a0X, Ma\u00a0R, Wang\u00a0W, Xiao\u00a0X, Tian\u00a0Z, et al. Activation and evasion of type I interferon responses by SARS-CoV\u20112. Nat Commun. 2020;11(1):3810.","journal-title":"Nat Commun"},{"issue":"6","key":"1763_CR44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad\u00a0M, Martin\u00a0JC. Pathological inflammation in patients with COVID-19: a\u00a0key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355\u201362.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1763_CR45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay\u00a0MZ, Poh\u00a0CM, R\u00e9nia\u00a0L, MacAry\u00a0PA, Ng\u00a0LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1763_CR46","doi-asserted-by":"crossref","first-page":"e20200678","DOI":"10.1084\/jem.20200678","volume":"217","author":"SA Vardhana","year":"2020","unstructured":"Vardhana\u00a0SA, Wolchok\u00a0JD. The many faces of the anti-COVID immune response. J\u00a0Exp Med. 2020;217(6):e20200678.","journal-title":"J Exp Med"},{"key":"1763_CR47","doi-asserted-by":"publisher","unstructured":"Altmann DM, Boyton RJ. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. Sci Immunol. 2020;5(49):eabd6160. https:\/\/doi.org\/10.1126\/sciimmunol.abd6160.","DOI":"10.1126\/sciimmunol.abd6160"},{"key":"1763_CR48","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3389\/fimmu.2020.01748","volume":"11","author":"LL Cunha","year":"2020","unstructured":"Cunha\u00a0LL, Perazzio\u00a0SF, Azzi\u00a0J, Cravedi\u00a0P, Riella\u00a0LV. Remodeling of the immune response with aging: Immunosenescence and its potential impact on COVID-19 immune response. Front Immunol. 2020;11:1748.","journal-title":"Front Immunol"},{"issue":"6501","key":"1763_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.abb0762","volume":"369","author":"AN Akbar","year":"2020","unstructured":"Akbar\u00a0AN, Gilroy\u00a0DW. Aging immunity may exacerbate COVID-19. Science. 2020;369(6501):256.","journal-title":"Science"},{"issue":"7","key":"1763_CR50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully\u00a0EP, Haverfield\u00a0J, Ursin\u00a0RL, Tannenbaum\u00a0C, Klein\u00a0SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1763_CR51","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.immuni.2020.08.003","volume":"53","author":"MJ Bunders","year":"2020","unstructured":"Bunders\u00a0MJ, Altfeld\u00a0M. Implications of sex differences in immunity for SARS-coV\u20112 pathogenesis and design of therapeutic interventions. Immunity. 2020;53(3):487\u201395.","journal-title":"Immunity"},{"key":"1763_CR52","doi-asserted-by":"publisher","unstructured":"Edridge AWD, Kaczorowska J, Hoste ACR, Bakker M, Klein M, Loens K, et al. Seasonal coronavirus protective immunity is short-lasting. Nature Medicine. 2020. https:\/\/doi.org\/10.1038\/s41591-020-1083-1.","DOI":"10.1038\/s41591-020-1083-1"},{"key":"1763_CR53","doi-asserted-by":"publisher","unstructured":"To KK-W, Hung IF-N, Ip JD, Chu AW-H, Chan W-M, Tam AR, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clinical infectious diseases 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1275.","DOI":"10.1093\/cid\/ciaa1275"},{"key":"1763_CR54","doi-asserted-by":"publisher","unstructured":"Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516\u201327. https:\/\/doi.org\/10.1038\/s41586-020-2798-3.","DOI":"10.1038\/s41586-020-2798-3"},{"issue":"10","key":"1763_CR55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","volume":"20","author":"M Jeyanathan","year":"2020","unstructured":"Jeyanathan\u00a0M, Afkhami\u00a0S, Smaill\u00a0F, Miller\u00a0MS, Lichty\u00a0BD, Xing\u00a0Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615\u201332.","journal-title":"Nat Rev Immunol"},{"key":"1763_CR56","doi-asserted-by":"publisher","unstructured":"Ca\u00f1ete PF, Vinuesa CG. COVID-19 Makes B Cells Forget, but T Cells Remember. Cell. 2020;183(1):13\u20135. https:\/\/doi.org\/10.1016\/j.cell.2020.09.013.","DOI":"10.1016\/j.cell.2020.09.013"},{"issue":"6512","key":"1763_CR57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","volume":"370","author":"J Mateus","year":"2020","unstructured":"Mateus\u00a0J, Grifoni\u00a0A, Tarke\u00a0A, Sidney\u00a0J, Ramirez\u00a0SI, Dan\u00a0JM, et al. Selective and cross-reactive SARS-CoV-2\u202fT cell epitopes in unexposed humans. Science. 2020;370(6512):89.","journal-title":"Science"},{"key":"1763_CR58","doi-asserted-by":"publisher","unstructured":"Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2598-9.","DOI":"10.1038\/s41586-020-2598-9"},{"key":"1763_CR59","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3389\/fimmu.2020.01880","volume":"11","author":"SO Alturki","year":"2020","unstructured":"Alturki\u00a0SO, Alturki\u00a0SO, Connors\u00a0J, Cusimano\u00a0G, Kutzler\u00a0MA, Izmirly\u00a0AM, et al. The 2020 pandemic: current SARS-coV\u20112 vaccine development. Front Immunol. 2020;11:1880.","journal-title":"Front Immunol"},{"issue":"10","key":"1763_CR60","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.mayocp.2020.07.021","volume":"95","author":"GA Poland","year":"2020","unstructured":"Poland\u00a0GA, Ovsyannikova\u00a0IG, Crooke\u00a0SN, Kennedy\u00a0RB. SARS-coV\u20112 vaccine development: current status. Mayo Clin Proc. 2020;95(10):2172\u201388.","journal-title":"Mayo Clin Proc"},{"key":"1763_CR61","doi-asserted-by":"publisher","unstructured":"Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase 1\/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589\u201393. https:\/\/doi.org\/10.1038\/s41586-020-2639-4.","DOI":"10.1038\/s41586-020-2639-4"},{"key":"1763_CR62","doi-asserted-by":"publisher","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA Vaccine against SARS-CoV-2 \u2014 Preliminary Report. New England Journal of Medicine. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2022483.","DOI":"10.1056\/NEJMoa2022483"},{"issue":"10249","key":"1763_CR63","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","volume":"396","author":"PM Folegatti","year":"2020","unstructured":"Folegatti\u00a0PM, Ewer\u00a0KJ, Aley\u00a0PK, Angus\u00a0B, Becker\u00a0S, Belij-Rammerstorfer\u00a0S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a\u00a0preliminary report of a\u00a0phase 1\/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467\u201378.","journal-title":"Lancet"},{"key":"1763_CR64","doi-asserted-by":"publisher","unstructured":"Peeples L. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine. Proceedings of the National Academy of Sciences. 2020;117(15):8218\u201321. https:\/\/doi.org\/10.1073\/pnas.2005456117.","DOI":"10.1073\/pnas.2005456117"},{"issue":"10","key":"1763_CR65","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","volume":"5","author":"WS Lee","year":"2020","unstructured":"Lee\u00a0WS, Wheatley\u00a0AK, Kent\u00a0SJ, DeKosky\u00a0BJ. Antibody-dependent enhancement and SARS-CoV\u20112 vaccines and therapies. Nat Microbiol. 2020;5(10):1185\u201391.","journal-title":"Nat Microbiol"},{"issue":"7821","key":"1763_CR66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41586-020-2538-8","volume":"584","author":"AM Arvin","year":"2020","unstructured":"Arvin\u00a0AM, Fink\u00a0K, Schmid\u00a0MA, Cathcart\u00a0A, Spreafico\u00a0R, Havenar-Daughton\u00a0C, et al. A perspective on potential antibody-dependent enhancement of SARS-CoV\u20112. Nature. 2020;584(7821):353\u201363.","journal-title":"Nature"},{"key":"1763_CR67","doi-asserted-by":"publisher","unstructured":"Yang J, Wang W, Chen Z, Lu S, Yang F, Bi Z, et al. A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020;586(7830):572\u20137. https:\/\/doi.org\/10.1038\/s41586-020-2599-8.","DOI":"10.1038\/s41586-020-2599-8"},{"key":"1763_CR68","series-title":"bioRxiv : the preprint server for biology: 2020.08.11.247395","volume-title":"Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2","author":"AC Walls","year":"2020","unstructured":"Walls\u00a0AC, Fiala\u00a0B, Sch\u00e4fer\u00a0A, Wrenn\u00a0S, Pham\u00a0MN, Murphy\u00a0M, et al. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV\u20112. bioRxiv : the preprint server for biology: 2020.08.11.247395. 2020."},{"issue":"5","key":"1763_CR69","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","volume":"27","author":"DR Burton","year":"2020","unstructured":"Burton\u00a0DR, Walker\u00a0LM. Rational vaccine design in the time of COVID-19. Cell Host Microbe. 2020;27(5):695\u20138.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"1763_CR70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chom.2020.07.018","volume":"28","author":"JB Case","year":"2020","unstructured":"Case\u00a0JB, Rothlauf\u00a0PW, Chen\u00a0RE, Kafai\u00a0NM, Fox\u00a0JM, Smith\u00a0BK, et al. Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-coV-2-mediated pathogenesis in mice. Cell Host Microbe. 2020;28(3):465\u2013474.e4.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"1763_CR71","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","volume":"11","author":"PF McKay","year":"2020","unstructured":"McKay\u00a0PF, Hu\u00a0K, Blakney\u00a0AK, Samnuan\u00a0K, Brown\u00a0JC, Penn\u00a0R, et al. Self-amplifying RNA SARS-CoV\u20112 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nat Commun. 2020;11(1):3523.","journal-title":"Nat Commun"},{"issue":"1","key":"1763_CR72","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","volume":"11","author":"TRF Smith","year":"2020","unstructured":"Smith\u00a0TRF, Patel\u00a0A, Ramos\u00a0S, Elwood\u00a0D, Zhu\u00a0X, Yan\u00a0J, et al. Immunogenicity of a\u00a0DNA vaccine candidate for COVID-19. Nat Commun. 2020;11(1):2601.","journal-title":"Nat Commun"},{"issue":"1","key":"1763_CR73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan\u00a0AO, Kafai\u00a0NM, Dmitriev\u00a0IP, Fox\u00a0JM, Smith\u00a0BK, Harvey\u00a0IB, et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-coV\u20112. Cell. 2020;183(1):169\u2013184.e13.","journal-title":"Cell"},{"key":"1763_CR74","doi-asserted-by":"publisher","unstructured":"MacLean OA, Orton RJ, Singer JB, Robertson DL. No evidence for distinct types in the evolution of SARS-CoV-2. Virus Evolution. 2020;6(1):veaa034. https:\/\/doi.org\/10.1093\/ve\/veaa034.","DOI":"10.1093\/ve\/veaa034"},{"key":"1763_CR75","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3389\/fphar.2020.01224","volume":"11","author":"S Iacob","year":"2020","unstructured":"Iacob\u00a0S, Iacob\u00a0DG. SARS-coV\u20112 treatment approaches: numerous options, no certainty for a\u00a0versatile virus. Front Pharmacol. 2020;11:1224.","journal-title":"Front Pharmacol"},{"key":"1763_CR76","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fmicb.2020.01818","volume":"11","author":"S IdA","year":"2020","unstructured":"IdA\u00a0S, Grosche\u00a0VR, Bergamini\u00a0FRG, Sabino-Silva\u00a0R, Jardim\u00a0ACG. Antivirals against Coronaviruses: candidate drugs for SARS-coV\u20112 treatment? Front Microbiol. 2020;11:1818.","journal-title":"Front Microbiol"},{"key":"1763_CR77","doi-asserted-by":"publisher","unstructured":"Pardo J, Shukla AM, Chamarthi G, Gupte A. The journey of remdesivir: from Ebola to COVID-19. Drugs Context. 2020;9:2020-4-14. https:\/\/doi.org\/10.7573\/dic.2020-4-14.","DOI":"10.7573\/dic.2020-4-14"},{"key":"1763_CR78","doi-asserted-by":"publisher","unstructured":"Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, et al. Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern Med. 2020. https:\/\/doi.org\/10.1001\/jamainternmed.2020.6319.","DOI":"10.1001\/jamainternmed.2020.6319"},{"key":"1763_CR79","doi-asserted-by":"publisher","unstructured":"Fiolet T, Guihur A, Rebeaud ME, Mulot M, Peiffer-Smadja N, Mahamat-Saleh Y. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. Clin Microbiol Infect. 2020. https:\/\/doi.org\/10.1016\/j.cmi.2020.08.022.","DOI":"10.1016\/j.cmi.2020.08.022"},{"issue":"11","key":"1763_CR80","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jama.2020.16337","volume":"324","author":"EK McCreary","year":"2020","unstructured":"McCreary\u00a0EK, Angus\u00a0DC. Efficacy of Remdesivir in COVID-19. JAMA. 2020;324(11):1041\u20132.","journal-title":"JAMA"},{"issue":"1","key":"1763_CR81","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","volume":"11","author":"L Fu","year":"2020","unstructured":"Fu\u00a0L, Ye\u00a0F, Feng\u00a0Y, Yu\u00a0F, Wang\u00a0Q, Wu\u00a0Y, et al. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV\u20112 by targeting its main protease. Nat Commun. 2020;11(1):4417.","journal-title":"Nat Commun"},{"issue":"7811","key":"1763_CR82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin\u00a0Z, Du\u00a0X, Xu\u00a0Y, Deng\u00a0Y, Liu\u00a0M, Zhao\u00a0Y, et al. Structure of Mpro from SARS-CoV\u20112 and discovery of its inhibitors. Nature. 2020;582(7811):289\u201393.","journal-title":"Nature"},{"issue":"6","key":"1763_CR83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","volume":"27","author":"Z Jin","year":"2020","unstructured":"Jin\u00a0Z, Zhao\u00a0Y, Sun\u00a0Y, Zhang\u00a0B, Wang\u00a0H, Wu\u00a0Y, et al. Structural basis for the inhibition of SARS-CoV\u20112 main protease by antineoplastic drug carmofur. Nat Struct Mol Biol. 2020;27(6):529\u201332.","journal-title":"Nat Struct Mol Biol"},{"key":"1763_CR84","doi-asserted-by":"publisher","unstructured":"Liu STH, Lin HM, Baine I, Wajnberg A, Gumprecht JP, Rahman F, et al. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study. Nat Med. 2020. https:\/\/doi.org\/10.1038\/s41591-020-1088-9.","DOI":"10.1038\/s41591-020-1088-9"},{"key":"1763_CR85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2020.04.031","volume":"144","author":"S Gro\u00df","year":"2020","unstructured":"Gro\u00df\u00a0S, Jahn\u00a0C, Cushman\u00a0S, B\u00e4r\u00a0C, Thum\u00a0T. SARS-CoV\u20112 receptor ACE2-dependent implications on the cardiovascular system: from basic science to clinical implications. J\u00a0Mol Cell Cardiol. 2020;144:47\u201353.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"1763_CR86","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil\u00a0V, Kwon\u00a0H, Prado\u00a0P, Hagelkr\u00fcys\u00a0A, Wimmer\u00a0RA, Stahl\u00a0M, et al. Inhibition of SARS-coV\u20112 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(4):905\u2013913.e7.","journal-title":"Cell"},{"issue":"7821","key":"1763_CR87","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani\u00a0DF, Gaebler\u00a0C, Muecksch\u00a0F, Lorenzi\u00a0JCC, Wang\u00a0Z, Cho\u00a0A, et al. Convergent antibody responses to SARS-CoV\u20112 in convalescent individuals. Nature. 2020;584(7821):437\u201342.","journal-title":"Nature"},{"issue":"7821","key":"1763_CR88","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","volume":"584","author":"SJ Zost","year":"2020","unstructured":"Zost\u00a0SJ, Gilchuk\u00a0P, Case\u00a0JB, Binshtein\u00a0E, Chen\u00a0RE, Nkolola\u00a0JP, et al. Potently neutralizing and protective human antibodies against SARS-CoV\u20112. Nature. 2020;584(7821):443\u20139.","journal-title":"Nature"},{"issue":"6506","key":"1763_CR89","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen\u00a0J, Baum\u00a0A, Pascal\u00a0KE, Russo\u00a0V, Giordano\u00a0S, Wloga\u00a0E, et al. Studies in humanized mice and convalescent humans yield a\u00a0SARS-CoV\u20112 antibody cocktail. Science. 2020;369(6506):1010.","journal-title":"Science"},{"issue":"4","key":"1763_CR90","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang\u00a0H, Penninger\u00a0JM, Li\u00a0Y, Zhong\u00a0N, Slutsky\u00a0AS. Angiotensin-converting enzyme 2 (ACE2) as a\u00a0SARS-CoV\u20112 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586\u201390.","journal-title":"Intensive Care Med"},{"issue":"11","key":"1763_CR91","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","volume":"172","author":"N Nathanson","year":"2010","unstructured":"Nathanson\u00a0N, Kew\u00a0OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol. 2010;172(11):1213\u201329.","journal-title":"Am J Epidemiol"},{"key":"1763_CR92","doi-asserted-by":"crossref","first-page":"100105","DOI":"10.1016\/j.bbih.2020.100105","volume":"7","author":"CDM Fulton","year":"2020","unstructured":"Fulton\u00a0CDM, Beasley\u00a0DWC, Bente\u00a0DA, Dineley\u00a0KT. Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models. Brain Behav Immun Health. 2020;7:100105.","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"1763_CR93","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.immuni.2020.04.016","volume":"52","author":"RL Graham","year":"2020","unstructured":"Graham\u00a0RL, Baric\u00a0RS. SARS-CoV-2: combating coronavirus emergence. Immunity. 2020;52(5):734\u20136.","journal-title":"Immunity"},{"issue":"5","key":"1763_CR94","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie\u00a0X, Muruato\u00a0A, Lokugamage\u00a0KG, Narayanan\u00a0K, Zhang\u00a0X, Zou\u00a0J, et al. An infectious cDNA clone of SARS-CoV\u20112. Cell Host Microbe. 2020;27(5):841\u2013848.e3.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"1763_CR95","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41594-020-0468-7","volume":"27","author":"AG Wrobel","year":"2020","unstructured":"Wrobel\u00a0AG, Benton\u00a0DJ, Xu\u00a0P, Roustan\u00a0C, Martin\u00a0SR, Rosenthal\u00a0PB, et al. SARS-CoV\u20112 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat Struct Mol Biol. 2020;27(8):763\u20137.","journal-title":"Nat Struct Mol Biol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-020-01763-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T12:06:50Z","timestamp":1618142810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-020-01763-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":95,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s00508-020-01763-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"12 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.X.\u00a0Heinz and K.\u00a0Stiasny declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}